SOPHiA GENETICS President and CEO Ross Muken discusses the use of AI and technology in diagnosing and treating patients, ...
Deep learning approaches have transformed how scientists predict the activity and function of DNA sequences in the genome. A ...
The Broad Institute, Boston Children’s Hospital, and Maine’s Jackson Laboratory announced a collaboration to develop rare ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces the full commercial launch of ...
Rare DNA changes are most strongly linked to cognition in early childhood, but the link fades as children age, while common ...
Summary: Researchers identified 11 independent genomic risk regions (loci) and 9 specific candidate genes linked to BPD ...
For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging ...
Genetics influences longevity by providing inherited characteristics related to health, but daily habits are also essential ...
Researchers have identified the first evidence of genetic risk factors associated with borderline personality disorder (BPD).
View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Myriad Genetics (NASDAQ:MYGN) and its peers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results